← Leaderboards
Meryl A Butters
University Of Pittsburgh At Pittsburgh
$8,957,313
Attributed
$10,244,254
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,244,254 · 8
By mechanism
R01$7,621,246 · 4
UG3$1,370,657 · 1
K01$582,042 · 1
P30$560,533 · 1
R21$109,776 · 1
Top collaborators
- Daniel Felsky1 shared
- Jordan F Karp1 shared
- Eric J Lenze1 shared
- Ginger E Nicol1 shared
- Aristotle Nicholas Voineskos1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Katalin None Szanto$10,528,387
- Jon W. Johnson$10,282,857
- Nadine M. Melhem$18,044,590
- Mingui Sun$11,879,919
- Yanhua H Huang$11,350,148
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposElderlyCognitiveGeriatric DepressionMental DepressionCognitive FunctionDementiaImpaired CognitionLeadLinkEnrollmentPathway InteractionsNeuroimagingPhenotypeIndexingS DiseaseBrainParticipantS Disease RiskMild Cognitive ImpairmentVascular DementiaRisk FactorsAgedFollow-Up
Grant awards (31)
Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)$1,370,657
UG3 · FY2024 · MH
Major Depression and Molecular Senescence: The Role of Sleep$109,776
R21 · FY2022 · AG · contact PI
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression$405,927
R01 · FY2021 · MH · contact PI
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression$431,795
R01 · FY2020 · MH · contact PI
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression$498,250
R01 · FY2019 · MH · contact PI
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression$380,830
R01 · FY2019 · MH · contact PI
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression$453,946
R01 · FY2018 · MH · contact PI
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression$452,360
R01 · FY2017 · MH · contact PI
Amyloid, White Matter Hyperintensities & Outcomes of Late-Life Depression$65,301
R01 · FY2014 · MH · contact PI
Amyloid, white matter hyperintensities & outcomes of late-life depression$357,729
R01 · FY2013 · MH · contact PI
PRC Project--Butters$182,409
P30 · FY2013 · MH · contact PI
Amyloid, white matter hyperintensities & outcomes of late-life depression$495,855
R01 · FY2012 · MH · contact PI
PRC Project--Butters$189,110
P30 · FY2012 · MH · contact PI
Amyloid, white matter hyperintensities & outcomes of late-life depression$170,493
R01 · FY2012 · MH · contact PI
Amyloid, white matter hyperintensities & outcomes of late-life depression$497,453
R01 · FY2011 · MH · contact PI
PRC Project--Butters$189,014
P30 · FY2011 · MH · contact PI
Amyloid, white matter hyperintensities & outcomes of late-life depression$507,714
R01 · FY2010 · MH · contact PI
Amyloid, white matter hyperintensities & outcomes of late-life depression$461,383
R01 · FY2009 · MH · contact PI
Pathways Linking Late-Life Depression to MCI & Dementia$334,377
R01 · FY2009 · MH · contact PI
Pathways Linking Late-Life Depression to MCI & Dementia$331,753
R01 · FY2009 · MH · contact PI
Pathways Linking Late-Life Depression to MCI & Dementia$322,885
R01 · FY2008 · MH · contact PI
Pharmacotherapy of Latelife Generalized Anxiety Disorder$160,517
R01 · FY2008 · MH · contact PI
Pathways Linking Late-Life Depression to MCI & Dementia$326,133
R01 · FY2007 · MH · contact PI
Pharmacotherapy of Latelife Generalized Anxiety Disorder$259,784
R01 · FY2007 · MH · contact PI
Pathways Linking Late-Life Depression to MCI & Dementia$351,200
R01 · FY2006 · MH · contact PI
Pathways Linking Late-Life Depression to MCI &Dementia$355,561
R01 · FY2005 · MH
COURSE OF COGNITIVE FUNCTIONING IN LATE LIFE DEPRESSION$116,519
K01 · FY2004 · MH
COURSE OF COGNITIVE FUNCTIONING IN LATE LIFE DEPRESSION$116,519
K01 · FY2003 · MH
COURSE OF COGNITIVE FUNCTIONING IN LATE LIFE DEPRESSION$116,519
K01 · FY2002 · MH
COURSE OF COGNITIVE FUNCTIONING IN LATE LIFE DEPRESSION$116,519
K01 · FY2001 · MH
COURSE OF COGNITIVE FUNCTIONING IN LATE LIFE DEPRESSION$115,966
K01 · FY2000 · MH